Skip to content

HAART reduces liver-related death risk, but hepatitis C infection increases risk, Italian study finds

HIV/HCV coinfected patients have poorer immunologic response to HIV treatment

Immune reconstitution syndrome risk highest in those commencing HIV therapy with advanced HIV disease

Mortality falls in HIV/HCV coinfected Spaniards after the introduction of effective HIV treatment

ICAAC: Switch from AZT or d4T to tenofovir may improve blood fat levels

Non-Hodgkin's lymphoma risk increased with prolonged high HIV viral load

ICAAC: HCV only factor associated with liver problems in patients starting HIV treatment in 2004

ICAAC: Factors unrelated to HIV or side-effects of HIV treatment major cause of illness in French cohort

ICAAC: New treatment for lipid problems shows promise in HIV patients